Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 6 of 6

Full-Text Articles in Medicine and Health Sciences

Oncolog, Volume 35, Number 04, October-December 1990, Staff Jan 1990

Oncolog, Volume 35, Number 04, October-December 1990, Staff

OncoLog MD Anderson's Report to Physicians (All issues)

  • Search Continues for the Cause of Cervical Cancer
  • Clinical Applications of Fine Needle Aspiration Increase
  • The Uncertain Role of Adjuvant Systemic Therapy
  • Breast Conservation Should Be the Patient's Choice


Rubella Susceptibility And Continuing Risk Of Infection In Pregnancy, Saadiya Rasul, Mohammad Khurshid, Javaid Rizvi, Shahbanu Rizvi Jan 1990

Rubella Susceptibility And Continuing Risk Of Infection In Pregnancy, Saadiya Rasul, Mohammad Khurshid, Javaid Rizvi, Shahbanu Rizvi

Section of Haematology/Oncology

Sera of 2000 pregnant women attending the antenatal clinic of the Aga Khan University Hospital were tested for rubella antibodies. Of these 1684(84.2%) were Immune and 316(15.8%) were susceptible to rubella. Majority (99.8%) of the women were Asian in origin. Susceptibility decreased with increasing age and parity. We conclude that apart from vaccination of all young children greater attention should be paid to immunization of women of child-bearing age


The Role Of Small Peptides In Cancer Physiology And Chemotherapy, Bao-Ling Tsay Jan 1990

The Role Of Small Peptides In Cancer Physiology And Chemotherapy, Bao-Ling Tsay

Theses and Dissertations in Biomedical Sciences

The targeting of proven anticancer drugs specifically to cancer cells would provide a unique opportunity to restrict neoplasms without damaging the cancer patient. The present research utilizes the phenomenon of illicit transport, i.e. the coupling of normally impermeant metabolites to permeant metabolites, in targeting the drug melphalan to mouse Ehrlich ascites tumor cells. The dipeptide beta-alanyl-melphalan was synthesized and tested in vitro for toxicity towards mouse Ehrlich ascites tumor cells, mouse liver cells, and mouse 3T3 embryonic cells. The parent compound, melphalan, was used as a control treatment. In addition, both melphalan and beta-alanyl-melphalan were utilized in in vivo chemotherapeutic …


Oncolog, Volume 35, Number 03, July-September 1990, Staff Jan 1990

Oncolog, Volume 35, Number 03, July-September 1990, Staff

OncoLog MD Anderson's Report to Physicians (All issues)

  • Treatment Team Addresses Needs of the Dying Patient
  • Fludarabine Opens a New Dimension in Chronic Lymphocytic Leukemia Research


Oncolog, Volume 35, Number 01, January-March 1990, Staff Jan 1990

Oncolog, Volume 35, Number 01, January-March 1990, Staff

OncoLog MD Anderson's Report to Physicians (All issues)

  • Is Malpractice Litigation Undermining Informed Consent?
  • Total Parenteral Nutrition: The Double-Edged Sword
  • Expandable Stents Provide Relief for Patients with Tumor-Compressed Tissue


Oncolog, Volume 35, Number 02, April-June 1990, Staff Jan 1990

Oncolog, Volume 35, Number 02, April-June 1990, Staff

OncoLog MD Anderson's Report to Physicians (All issues)

  • Chemotherapy for Brain Metastasis Sees Progress in the Last Decade
  • Researchers Hope Chemoprevention Will Reverse Tumorigenic Process
  • Immunocytochemical Assays for Steroid Receptors: A New Application for Fine Needle Aspiration